Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $23.84 in the prior trading day, Acadia Healthcare Company Inc (NASDAQ: ACHC) closed at $23.91, up 0.29%. In other words, the price has increased by $0.29 from its previous closing price. On the day, 6.31 million shares were traded. ACHC stock price reached its highest trading level at $24.34 during the session, while it also had its lowest trading level at $23.36.
Ratios:
Our goal is to gain a better understanding of ACHC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.00. In the meantime, Its Debt-to-Equity ratio is 0.68 whereas as Long-Term Debt/Eq ratio is at 0.65.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Barclays on February 28, 2025, Downgraded its rating to Equal Weight and sets its target price to $35 from $43 previously.
On January 07, 2025, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $70.
Deutsche Bank Upgraded its Hold to Buy on December 12, 2024, whereas the target price for the stock was revised from $45 to $75.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 30 ’24 when Hollinsworth John S. bought 20,000 shares for $53.02 per share.
Hollinsworth John S. bought 10,000 shares of ACHC for $812,065 on Aug 29 ’24. On Aug 08 ’24, another insider, Hollinsworth John S., who serves as the Officer of the company, bought 5,000 shares for $71.57 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHC now has a Market Capitalization of 2202775808 and an Enterprise Value of 4358454784. As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 8.61, and their Forward P/E ratio for the next fiscal year is 7.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.70 while its Price-to-Book (P/B) ratio in mrq is 0.71. Its current Enterprise Value per Revenue stands at 1.382 whereas that against EBITDA is 6.487.
Stock Price History:
The Beta on a monthly basis for ACHC is 1.06, which has changed by -0.6596925 over the last 52 weeks, in comparison to a change of 0.05430484 over the same period for the S&P500. Over the past 52 weeks, ACHC has reached a high of $82.40, while it has fallen to a 52-week low of $23.79. The 50-Day Moving Average of the stock is -26.10%, while the 200-Day Moving Average is calculated to be -52.54%.
Shares Statistics:
The stock has traded on average 1.99M shares per day over the past 3-months and 3266810 shares per day over the last 10 days, according to various share statistics. A total of 91.78M shares are outstanding, with a floating share count of 89.71M. Insiders hold about 2.63% of the company’s shares, while institutions hold 107.96% stake in the company. Shares short for ACHC as of 1743379200 were 7093937 with a Short Ratio of 3.56, compared to 1740700800 on 5121262. Therefore, it implies a Short% of Shares Outstanding of 7093937 and a Short% of Float of 7.79.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
A comprehensive evaluation of Acadia Healthcare Company Inc (ACHC) is underway, with the input of 12.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.75, with high estimates of $0.88 and low estimates of $0.65.
Analysts are recommending an EPS of between $2.76 and $2.51 for the fiscal current year, implying an average EPS of $2.66. EPS for the following year is $3.01, with 13.0 analysts recommending between $3.36 and $2.66.
Revenue Estimates
11 analysts predict $769.84M in revenue for the current quarter. It ranges from a high estimate of $771.89M to a low estimate of $767.8M. As of the current estimate, Acadia Healthcare Company Inc’s year-ago sales were $768.05MFor the next quarter, 11 analysts are estimating revenue of $845.71M. There is a high estimate of $860.75M for the next quarter, whereas the lowest estimate is $826M.
A total of 12 analysts have provided revenue estimates for ACHC’s current fiscal year. The highest revenue estimate was $3.36B, while the lowest revenue estimate was $3.3B, resulting in an average revenue estimate of $3.34B. In the same quarter a year ago, actual revenue was $3.15BBased on 12 analysts’ estimates, the company’s revenue will be $3.62B in the next fiscal year. The high estimate is $3.7B and the low estimate is $3.53B.
